Daniel F. Hayes, MD, FASCO, has been elected president of the American Society of Clinical Oncology.
Daniel F. Hayes, MD, FASCO, has been elected president of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2016. He will take office as president-elect during the ASCO Annual Meeting in Chicago in June 2015. Additionally, 4 new members were elected to the ASCO Board of Directors and 2 new members to the ASCO Nominating Committee.
“I’m honored to be elected incoming president of ASCO, which has had such a major influence on my professional career,” said Dr Hayes. “I look forward to working with ASCO leadership and staff on the critical initiatives within the oncology community including new strategies for health care reform; the development of CancerLinQ; efforts to improve value in cancer care; personalized cancer care; and reducing global disparities in cancer treatment. ASCO is uniquely positioned to tackle these issues head-on, and I look forward to being part of this exciting time in the life of the Society.”
Link to the complete press release: http://bit.ly/1GSXm7e
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen